David Climie
Plus aucun poste en cours
Historique de carrière de David Climie
Anciens postes connus de David Climie
Sociétés | Poste | Début | Fin |
---|---|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Investor Relations Contact | 01/05/2011 | - |
Public Communications Contact | 01/05/2011 | - | |
PMC-SIERRA INC | Investor Relations Contact | 19/10/2011 | - |
Public Communications Contact | - | - | |
Sales & Marketing | - | - |
Statistiques
Internationale
Etats-Unis | 2 |
Canada | 2 |
Opérationnelle
Investor Relations Contact | 2 |
Public Communications Contact | 2 |
Sales & Marketing | 1 |
Sectorielle
Electronic Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Microsemi Storage Solutions, Inc.
Microsemi Storage Solutions, Inc. SemiconductorsElectronic Technology Microsemi Storage Solutions, Inc. engages in the design, development, marketing, and support of semiconductor solutions by integrating its mixed-signal, software, and systems expertise through a network of offices in North America, Europe, and Asia. The company was founded by James V. Diller, Sr., Colin C. Harris, Brian Gerson, Gregory D. Aasen, Glenn Bindley, and Kevin Huscroft in 1984 and is headquartered in Sunnyvale, CA. | Electronic Technology |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
- Bourse
- Insiders
- David Climie
- Expérience